Eli Lilly LLY
NYSE LLY
$1,143.30 -6.79 (-0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eli Lilly (LLY) Net Income (2009 - 2026)

Updated

Eli Lilly (LLY) reported Net Income of $7.1 billion for Q2 2026, up 25.3% from $5.66 billion a year earlier but down 4.1% from the prior quarter.

Analysis

Eli Lilly (LLY) Net Income (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Eli Lilly's Net Income came in at $26.71 billion, up 93.6% year-over-year; for FY2025, it was $20.64 billion, up 94.9% from FY2024.

  • Net Income has a five-year compound annual growth rate of 27.2% (FY2020 to FY2025).
  • By year, Net Income came in at $10.59 billion in FY2024 (+102.1%), $5.24 billion in FY2023 (-16.1%), $6.24 billion in FY2022 (+11.9%) and $5.58 billion in FY2021 (-9.9%).
  • Five-year quarterly Net Income spans a low of -$57.4 million in Q3 2023 and a high of $7.4 billion in Q1 2026.
  • Year over year, Net Income has now increased in each of the last seven quarters, with growth averaging 133.5% over the last seven quarters.
  • The high point for year-over-year Net Income in five years was Q3 2025 (growth of 475.3%); the low point was Q2 2022 (a decline of 31.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $7.4 billion (Q1 2026), $6.64 billion (Q4 2025) and $5.58 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.10 Bn
Mar 31, 2026 7.40 Bn
Dec 31, 2025 6.64 Bn
Sep 30, 2025 5.58 Bn
Jun 30, 2025 5.66 Bn
Mar 31, 2025 2.76 Bn
Dec 31, 2024 4.41 Bn
Sep 30, 2024 970.30 Mn
Jun 30, 2024 2.97 Bn
Mar 31, 2024 2.24 Bn
Dec 31, 2023 2.19 Bn
Sep 30, 2023 -57.40 Mn
Jun 30, 2023 1.76 Bn
Mar 31, 2023 1.34 Bn
Dec 31, 2022 1.94 Bn
Sep 30, 2022 1.45 Bn
Jun 30, 2022 952.50 Mn
Mar 31, 2022 1.90 Bn
Dec 31, 2021 1.73 Bn
Sep 30, 2021 1.11 Bn
API Access

Eli Lilly Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=LLY&period=max&api_key=YOUR_API_KEY